For example, prolonged treatment of BRAFV600E-expressing melanoma cells with the BRAF inhibitor AZ628, leads to the development of clones that maintain high levels of phosphorylated ERK, which continue to proliferate in the presence of drug (Montagut et al, 2008). This evidence concerns the gene BRAF and melanoma.